SARS-CoV-2 antibody seroprevalence and associated risk factors in an urban district of Cameroon. Preprint
GHDx Entry last modified on: May 12, 2022
Blood tests
Dataset Records for Blood tests
Displaying 251 - 300 of 1862
Seroprevalence of SARS-CoV-2 antibodies in Saint Petersburg, Russia: a population-based study
GHDx Entry last modified on: Mar 14, 2022
South Korea National Health and Nutrition Examination Survey 2020
KNHANES VIII 2nd (2020)
Survey:
Cross-sectional - Exam - Individual - Nationally representative
High SARS-CoV-2 Seroprevalence in Children and Adults in the Austrian Ski Resort Ischgl. Preprint
GHDx Entry last modified on: Mar 14, 2022
Seroprevalence of antibodies to SARS-CoV-2 among blood donors in the early months of the pandemic in Saudi Arabia
GHDx Entry last modified on: Jun 17, 2021
Seroprevalence of anti-SARS-COV-2 antibodies in blood donors from Nuevo Leon state, Mexico, during the beginning of the COVID-19 pandemic. Preprint
GHDx Entry last modified on: Mar 14, 2022
Coronavirus antibody screening identifies children with mild to moderate courses of PMIS
GHDx Entry last modified on: Mar 14, 2022
Is Karachi Knocking at Herd Immunity? A Possible Reason for Decline in SARS-CoV-2 Infections. Preprint
GHDx Entry last modified on: Mar 14, 2022
SARS-CoV-2 Seroprevalence in Aden, Yemen a Population-Based Study. Preprint
GHDx Entry last modified on: May 12, 2022
Niger Health Statistical Yearbook 2020
Annuaire Des Statistiques Sanitaires Niger, 2020
Report:
Epi surveillance - Subnationally representative
India Integrated Disease Surveillance Programme (IDSP): Weekly Outbreak Reports for 2023
Disease Alerts/Outbreaks Reported and Responded to by States/UTs through Integrated Disease Surveillance Programme (IDSP)
Epi surveillance:
Subnationally representative
Findings from serological surveys (in August 2020) to assess the exposure of adult population to SARS Cov-2 infection in three cities of Odisha, India. Preprint.
GHDx Entry last modified on: Mar 14, 2022
Temporal trends of SARS-CoV-2 seroprevalence in transfusion blood donors during the first wave of the COVID-19 epidemic in Kenya
GHDx Entry last modified on: Mar 14, 2022
Lack of Antibodies to SARS-CoV-2 among Blood Donors during COVID-19 Lockdown: A Study from Saudi Arabia
GHDx Entry last modified on: Mar 14, 2022
COVID Seroprevalence, Symptoms and Mortality During the First Wave of SARS-CoV-2 in Canada
GHDx Entry last modified on: May 12, 2022
Rapidly increasing SARS-CoV-2 seroprevalence and limited clinical disease in three Malian communities: a prospective cohort study. Preprint
GHDx Entry last modified on: May 12, 2022
Infections in Oxfordshire Research Database (IORD) 2020
Administrative data:
Exam - Inpatient
SARS-CoV-2: seroepidemiological pattern in northeastern Bulgaria
GHDx Entry last modified on: Mar 14, 2022
Assessing seropositivity for IgG antibodies against SARS-CoV-2 in Ahmedabad city of India: a cross-sectional study
GHDx Entry last modified on: Jan 31, 2024
Seroprevalence of SARS-CoV-2 immunoglobulin antibodies in Wuhan, China: part of the city-wide massive testing campaign
GHDx Entry last modified on: Jan 31, 2024
SARS-CoV-2 has been circulating in northeastern Brazil since February 2020: evidence for antibody detection in asymptomatic patients
GHDx Entry last modified on: Mar 14, 2022
Surveillance and Seroprevalence: Evaluation of IgG antibodies for SARS-Cov2 by ELISA in the popular neighborhood Villa Azul, Quilmes, province of Buenos Aires, Argentina. Preprint
GHDx Entry last modified on: Mar 14, 2022
Population-Based Study of anti-SARS-CoV-2, Social Distancing and Government Responses in Joinville, Brazil. Preprint
GHDx Entry last modified on: Mar 14, 2022
Population-Based Serosurvey for Severe Acute Respiratory Syndrome Coronavirus 2 Transmission, Chennai, India
GHDx Entry last modified on: Jan 31, 2024
Serology- and PCR-based cumulative incidence of SARS-CoV-2 infection in adults in a successfully contained early hotspot (CoMoLo study), Germany, May to June 2020
GHDx Entry last modified on: Jan 31, 2024
Prevalence and Risk Factors of Infection in the Representative COVID-19 Cohort Munich. Preprint
GHDx Entry last modified on: Mar 14, 2022
Prevalence evolution of SARS-CoV-2 infection in the Municipality of São Paulo, 2020 - 2021
GHDx Entry last modified on: May 12, 2022
High anti-SARS-CoV-2 antibody seroconversion rates before the second wave in Manaus, Brazil, and the protective effect of social behavior measures: Results from the DETECTCoV-19 cohort. Preprint
GHDx Entry last modified on: Mar 14, 2022
Seroprevalence of SARS-CoV-2, symptom profiles and seroneutralization during the first COVID-19 wave in a suburban area, France. Preprint
GHDx Entry last modified on: Mar 14, 2022
Seropositive Prevalence of Antibodies Against SARS-CoV-2 in Wuhan, China
GHDx Entry last modified on: Jan 31, 2024
Charting Elimination in the Pandemic: A SARS-CoV-2 Serosurvey of Blood Donors in New Zealand. Preprint
GHDx Entry last modified on: Mar 14, 2022
Low prevalence of antibodies against SARS-CoV-2 among voluntary blood donors in Guangzhou, China
GHDx Entry last modified on: Jan 31, 2024
A longitudinal seroprevalence study in a large cohort of working adults reveals that neutralising SARS-CoV-2 RBD-specific antibodies persist for at least six months independent of the severity of symptoms. Preprint
GHDx Entry last modified on: Jun 18, 2021
Seroprevalence of SARS-CoV-2 significantly varies with age: Preliminary results from a mass population screening
GHDx Entry last modified on: Jun 17, 2021
Prevalence of SARS-CoV-2 IgG antibodies in an area of northeastern Italy with a high incidence of COVID-19 cases: a population-based study
GHDx Entry last modified on: Mar 14, 2022
Saint Lucia STEPS Noncommunicable Disease Risk Factors Survey 2019-2020
Survey:
Cross-sectional - Individual - Interview
Rwanda Demographic and Health Survey 2019-2020
Survey:
Cross-sectional - Household - Individual - Nationally representative - Urban-rural representative
Social Determinants of Health and Risk of SARS-CoV-2 Infection in Community-Dwelling Older Adults Living in a Rural Latin American Setting
GHDx Entry last modified on: Mar 14, 2022
SARS-CoV-2 in rural Latin America. A population-based study in coastal Ecuador
GHDx Entry last modified on: Mar 14, 2022
Gabon Demographic and Health Survey 2019-2021
Enquête Démographique et de Santé 2019-2021 (EDSG-III)
Survey:
Cross-sectional - GPS coordinates (GIS) - Household - Individual - Interview - Nationally representative - Subnationally representative - Urban-rural representative
Gambia Demographic and Health Survey 2019-2020
2019-20 GDHS
Survey:
Cross-sectional - GPS coordinates (GIS) - Household - Individual - Interview - Nationally representative - Subnationally representative - Urban-rural representative
Mauritania Demographic and Health Survey 2019-2020
Mauritanie Enquête Démographique et de Santé 2019-2020
Survey:
Cross-sectional - GPS coordinates (GIS) - Household - Individual - Interview - Nationally representative - Urban-rural representative
Japan National Health and Nutrition Survey 2019
国民健康・栄養調査
Survey:
Cross-sectional - Household - Individual - Interview
Liberia Demographic and Health Survey 2019-2020
Liberia DHS 2019
Survey:
Cross-sectional - GPS coordinates (GIS) - Household - Individual - Interview - Nationally representative
Ghana Malaria Indicator Survey 2019
Survey:
Cross-sectional - Household - Individual - Interview - Nationally representative - Subnationally representative - Urban-rural representative
Mongolia STEPS Noncommunicable Disease Risk Factors Survey 2019
Mongolia STEPS 2019
Survey:
Cross-sectional - Emergency - Household - Individual - Inpatient - Nationally representative
Malaysia National Health and Morbidity Survey 2019
National Health and Morbidity Survey 2019: Non-communicable diseases, healthcare demand and health literacy
Survey:
Cross-sectional - Individual - Interview - Nationally representative - Urban-rural representative
Ukraine STEPS Noncommunicable Disease Risk Factors Survey 2019
Ukraine STEPS 2019
Survey:
Cross-sectional - Household - Individual - Nationally representative
Sustained seroprevalence of anti SARS-CoV-2 total immunoglobulins in asymptomatic blood donors. Preprint
GHDx Entry last modified on: Mar 14, 2022
Panama National Health Survey 2019
Encuesta Nacional de Salud de Panama (ENSPA)
Survey:
Cross-sectional - Household - Individual - Interview - Nationally representative - Subnationally representative - Urban-rural representative
Subscribe